Non-Discrimination Notice

UPWARD

UPWARD– A study of Xtandi in men with prostate cancer

Some Requirements:

1. Male age 18 or over
2. Meet PSA criteria

Sponsored by: Astellas
Length of Study: 1 year
Enrollment: Closed

Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.

Research Department (315) 478-4185, option 7

Our Investigator for this study is Christopher Pieczonka, M.D.